Biotech http://www.remuun.com/ ↗
Company facts
- Founded
- 2025
- Headquarters
- Switzerland
About
The development of monoclonal antibody (mAb) therapies is a cornerstone of modern medicine, revolutionizing treatment across diverse disease areas. The field has a market value of CHF 300 billion per annum:Problem: Current antibody development is slow, expensive, and limits therapeutic potential. Understanding and harn…